ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Tea drinkers have lower glaucoma risk

Why Is Chlorella Considered a Superfood?

Soy, cruciferous vegetables could help lower breast cancer treatment side effects

The Long-Term Benefits of Drinking Oolong Tea

Wonderful White Tea: A Drink Fit for an Emperor

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

 
Print Page
Email Article

New Findings Show Reminyl® Slows Cognitive Decline By 60 % in Alzheimer's

  [ 167 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 23, 2003


Treatment with Reminyl® (galantamine hydrobromide) may slow the progression of mild to moderate Alzheimer's disease by 50 to 60 percent when used continuously for 48 months, according to a new study presented at the 156th Annual Meeting of the American Psychiatric Association.

The data showed that more than 12 percent of patients did not deteriorate at all. While the remaining patients showed varying degrees of deterioration, the investigators concluded that it was less than would be expected in an untreated Alzheimer's disease population. With 240 patients evaluated over the full 48 months, this is the largest long-term study of its kind.

"This study provides additional evidence that long-term therapy with Reminyl can have long-term benefits, by delaying the natural rate of decline," said Luc Truyen, M.D., Ph.D., Senior Director, Clinical Development, CNS, Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), and a study co-author. "For participants in this four-year study, cognitive decline was significantly delayed compared to the natural rate of decline in untreated patients."

Dr. Truyen noted that Alzheimer's disease typically progresses over the course of 10 years, and that the data showed continuous benefit from Reminyl during the entire four-year period.

The study consisted of open-label extensions of two double-blind, placebo- controlled trials. Patients received 24 to 32 mg of Reminyl daily during the initial three to six month blinded portions of the research; during the open-label extensions, the 240 patients received 24 mg of Reminyl every day.

The research focused on patients' cognitive performance, which includes the ability to think, reason and learn. Among participants receiving Reminyl, scores on the cognitive portion of the Alzheimer's Disease Assessment Scale (ADAS-cog) deteriorated 12.8 points. This compares to an expected decline of 24 to 36 points for untreated patients, based on the Stern equation, a standard measurement of cognitive decline in people with Alzheimer's disease.

Reminyl is thought to inhibit an enzyme that breaks down acetylcholine -- a neurotransmitter in the brain that plays a key role in memory and learning. In addition, it is believed that Reminyl modulates the brain's nicotinic receptors, to which acetylcholine binds. The clinical significance of these mechanisms is unknown.

"These findings should give Alzheimer's disease patients and caregivers hope that the progression of symptoms in this disabling disorder can be slowed for many sufferers, an important consideration as families and patients focus on getting the most out of the time they have," said Gordon Wilcock, Professor of Care of The Elderly, University of Bristol, UK, and a study investigator.



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Energy NADH™ 12.5mg Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
The Super Antioxidant for Brain, Joint and Heart Health The Super Antioxidant for Brain, Joint and Heart Health
The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map